Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells.

書誌詳細
主要な著者: Niimi, M, Ikeda, Y, Shirasugi, N, Shatari, T, Takami, H, Kodaira, S, Matsumoto, K, Hamano, K, Esato, K, Hara, M, Wood, K
フォーマット: Conference item
出版事項: 2000

類似資料